Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

McKesson
Merck
Harvard Business School
Mallinckrodt
McKinsey
Boehringer Ingelheim

Last Updated: November 21, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Nomegestrol acetate

See Plans and Pricing

« Back to Dashboard

What is the drug development status for Nomegestrol acetate?

Nomegestrol acetate is an investigational drug.

There have been 15 clinical trials for Nomegestrol acetate. The most recent clinical trial was a Phase 3 trial, which was initiated on January 21st 2017.

The most common disease conditions in clinical trials are Dysmenorrhea, Sclerosis, and Recurrence. The leading clinical trial sponsors are Merck Sharp & Dohme Corp., Mahidol University, and Theramex.

There are one hundred and fifty-five US patents protecting this investigational drug and one international patent.

Recent Clinical Trials for Nomegestrol acetate
TitleSponsorPhase
Bioequivalence of Two Fixed-dose Combination Tablets Containing Estradiol and Nomegestrol AcetateGrĂ¼nenthal S.A.Phase 1
Bioequivalence of Two Fixed-dose Combination Tablets Containing Estradiol and Nomegestrol AcetateGrĂ¼nenthal GmbHPhase 1
Ovulation and Follicular Development Associated With Mid Follicular Phase Initiation of Combined Hormonal ContraceptionMahidol UniversityPhase 4

See all Nomegestrol acetate clinical trials

Clinical Trial Summary for Nomegestrol acetate

Top disease conditions for Nomegestrol acetate
Top clinical trial sponsors for Nomegestrol acetate

See all Nomegestrol acetate clinical trials

US Patents for Nomegestrol acetate

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Nomegestrol acetate   Start Trial Heterocyclic compound Takeda Pharmaceutical Company Limited (Osaka, JP)   Start Trial
Nomegestrol acetate   Start Trial Methods and compositions for treating infection UNIVERSITY OF ROCHESTER (Rochester, NY) UNIVERSITY OF KANSAS (Lawrence, KS)   Start Trial
Nomegestrol acetate   Start Trial Neuroprotection and myelin repair using Nestorone.RTM. The Population Council, Inc. (New York, NY)   Start Trial
Nomegestrol acetate   Start Trial Heterocyclic compound Takeda Pharmaceutical Company Limited (Osaka, JP)   Start Trial
Nomegestrol acetate   Start Trial Heterocyclic compound Takeda Pharmaceutical Company Limited (Osaka, JP)   Start Trial
Nomegestrol acetate   Start Trial Heterocyclic compounds and their use as retinoid-related orphan receptor (ROR) gamma-T inhibitors Takeda Pharmaceutical Company Limited (Osaka, JP)   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Nomegestrol acetate

Drugname Country Document Number Estimated Expiration Related US Patent
Nomegestrol acetate Canada 2961033 2034-09-11   Start Trial
Nomegestrol acetate European Patent Office 3192791 2034-09-11   Start Trial
Nomegestrol acetate Japan WO2016039408 2034-09-11   Start Trial
Nomegestrol acetate World Intellectual Property Organization (WIPO) 2016039408 2034-09-11   Start Trial
Nomegestrol acetate World Intellectual Property Organization (WIPO) 2014052836 2032-09-27   Start Trial
Nomegestrol acetate Australia 2010308308 2029-10-19   Start Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Dow
Moodys
Medtronic
Boehringer Ingelheim
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.